A Study of RGX-104 in Patients With Advanced Lung & Endometrial Cancer

Clinical trial NCT02922764 · COMPLETED

Trial details

NCT number: NCT02922764
Sponsor: Inspirna, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Endometrial Cancer Endometrial Cancer Recurrent Lung Cancer Recurrent Lung Cancer Non-small Cell Lung Cancer Metastatic Non-small Cell Carcinoma

Start date: 2016-11-01
Primary completion: 2025-01-22
Enrollment: 146

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.